Aadi Bioscience (AADI) Competitors

Aadi Bioscience (NASDAQ:AADI) and Akoya Biosciences (NASDAQ:AKYA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, community ranking, risk and valuation.

Which has more risk and volatility, AADI or AKYA?

Aadi Bioscience has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Akoya Biosciences has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500.

Is AADI or AKYA more profitable?

Akoya Biosciences has a net margin of -72.68% compared to Aadi Bioscience's net margin of -288.72%. Aadi Bioscience's return on equity of -61.83% beat Akoya Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aadi Bioscience	-288.72%	-61.83%	-51.52%
Akoya Biosciences	-72.68%	-111.80%	-35.13%

Which has higher valuation and earnings, AADI or AKYA?

Akoya Biosciences has higher revenue and earnings than Aadi Bioscience. Akoya Biosciences is trading at a lower price-to-earnings ratio than Aadi Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aadi Bioscience	$24.35M	1.81	-$65.76M	-$2.55	-0.71
Akoya Biosciences	$96.63M	1.10	-$63.32M	-$1.47	-1.46

Does the MarketBeat Community prefer AADI or AKYA?

Akoya Biosciences received 17 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 60.87% of users gave Akoya Biosciences an outperform vote while only 47.83% of users gave Aadi Bioscience an outperform vote.

Company	Underperform	Outperform
Aadi Bioscience	Outperform Votes 11 47.83%	Underperform Votes 12 52.17%
Akoya Biosciences	Outperform Votes 28 60.87%	Underperform Votes 18 39.13%

Do analysts rate AADI or AKYA?

Aadi Bioscience currently has a consensus price target of $20.50, indicating a potential upside of 1,038.89%. Akoya Biosciences has a consensus price target of $7.79, indicating a potential upside of 262.13%. Given Aadi Bioscience's higher probable upside, equities analysts plainly believe Aadi Bioscience is more favorable than Akoya Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aadi Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Akoya Biosciences	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

Do institutionals & insiders hold more shares of AADI or AKYA?

52.1% of Aadi Bioscience shares are owned by institutional investors. Comparatively, 79.4% of Akoya Biosciences shares are owned by institutional investors. 37.3% of Aadi Bioscience shares are owned by company insiders. Comparatively, 7.3% of Akoya Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the media refer more to AADI or AKYA?

In the previous week, Aadi Bioscience and Aadi Bioscience both had 4 articles in the media. Akoya Biosciences' average media sentiment score of 0.84 beat Aadi Bioscience's score of 0.53 indicating that Akoya Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aadi Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Akoya Biosciences	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Akoya Biosciences beats Aadi Bioscience on 12 of the 17 factors compared between the two stocks.